We have located links that may give you full text access.
Mutations in the promoter, intron and CDS of two FAD2 generate multiple alleles modulating linoleic acid level in yellow mustard.
Scientific Reports 2017 August 16
Linoleic acid (C18:2) is an important polyunsaturated fatty acid in the seed oil of many crops. Here, we report that mutations in the promoter, intron and CDS of the FAD2 genes SalFAD2.LIA1 and SalFAD2.LIA2 generate three alleles LIA (1a) , LIA (1b) and lia (1) and two alleles LIA (2) and lia (2), respectively, controlling the C18:2 variation (4.4-32.7%) in yellow mustard. The allelic effect on increasing C18:2 content is LIA (1a) > LIA (1b) > lia (1) , LIA (2) > lia (2), and LIA (1a) > LIA (2). The five FAD 2 alleles each contain two exons, one intron and a promoter adjacent to exon 1. LIA (1a) has a 1152 bp CDS, a 1221 bp intron with promoter function and a 607 bp promoter. Compared with LIA (1a) , the intron of LIA (1b) has reduced promoter activity and that of LIA (2) and lia (2) has no promoter function due to extensive SNP and indel mutations. lia (1) differed from LIA (1b) by having an insertion of 1223 bp retrotransposon in its intron. lia (2) with mutations in the promoter has reduced promoter activity compared with LIA (2) . This study revealed that complex quantitative variation of trait phenotype in plants could be modulated by multiple alleles of oligogenic loci resulting from mutations in the regulatory region and CDS.
Full text links
Related Resources
Trending Papers
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app